Ranbaxy determined to restore "rightful" place with GMP compliance efforts, says CEO
This article was originally published in Scrip
Executive Summary
Ranbaxy's CEO and managing director Arun Sawhney says that the company is determined to find its rightful place in the minds of regulators and customers after a string of recent GMP compliance setbacks, including a US FDA import alert against its Mohali facility in 2013.